🚀 VC round data is live in beta, check it out!
Lavena - Shumen Valuation Multiples
Discover revenue and EBITDA valuation multiples for Lavena - Shumen and similar public comparables like Promisia Healthcare, Big Tree Cloud Holdings, Aroma, La savonnerie de Nyons and more.
Lavena - Shumen Overview
About Lavena - Shumen
Lavena AD - Shumen is a Bulgarian cosmetic manufacturer. The company manufactures a variety of personal hygiene and skincare items, including creams, oils, shampoos, soaps, gels, wet wipes, toothpaste, and sprays. It operates under the brands Bebble, Maternea, Footness, Hands@Work, Sport Ready, and MyRose.
Founded
1962
HQ
Employees
151
Website
Sectors
Financials (FY)
EV
$13M
Lavena - Shumen Financials
Lavena - Shumen reported last fiscal year revenue of $15M and EBITDA of $3M.
In the same fiscal year, Lavena - Shumen generated $8M in gross profit, $3M in EBITDA, and $1M in net income.
Lavena - Shumen P&L
In the most recent fiscal year, Lavena - Shumen reported revenue of $15M and EBITDA of $3M.
Lavena - Shumen expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $15M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $8M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 52% | XXX | XXX | XXX |
| EBITDA | — | XXX | $3M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 18% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 11% | XXX | XXX | XXX |
| Net Profit | — | XXX | $1M | XXX | XXX | XXX |
| Net Margin | — | XXX | 9% | XXX | XXX | XXX |
| Net Debt | — | — | $589K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Lavena - Shumen Stock Performance
Lavena - Shumen has current market cap of $13M, and enterprise value of $13M.
Market Cap Evolution
Lavena - Shumen's stock price is $1.28.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13M | $13M | 0.0% | XXX | XXX | XXX | $0.13 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLavena - Shumen Valuation Multiples
Lavena - Shumen trades at 0.8x EV/Revenue multiple, and 4.5x EV/EBITDA.
Lavena - Shumen Financial Valuation Multiples
As of March 30, 2026, Lavena - Shumen has market cap of $13M and EV of $13M.
Equity research analysts estimate Lavena - Shumen's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Lavena - Shumen has a P/E ratio of 9.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $13M | XXX | $13M | XXX | XXX | XXX |
| EV (current) | $13M | XXX | $13M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 4.5x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 7.5x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.6x | XXX | XXX | XXX |
| P/E | — | XXX | 9.7x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 8.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Lavena - Shumen Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Lavena - Shumen Margins & Growth Rates
Lavena - Shumen's revenue in the last fiscal year grew by 8%.
Lavena - Shumen's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Lavena - Shumen Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 13% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 41% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Lavena - Shumen Public Comps
See public comps and valuation multiples for other Health & Beauty comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Promisia Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Big Tree Cloud Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Aroma | XXX | XXX | XXX | XXX | XXX | XXX |
| La savonnerie de Nyons | XXX | XXX | XXX | XXX | XXX | XXX |
| Cosma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Lavena - Shumen M&A Activity
Lavena - Shumen acquired XXX companies to date.
Last acquisition by Lavena - Shumen was on XXXXXXXX, XXXXX. Lavena - Shumen acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Lavena - Shumen
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLavena - Shumen Investment Activity
Lavena - Shumen invested in XXX companies to date.
Lavena - Shumen made its latest investment on XXXXXXXX, XXXXX. Lavena - Shumen invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Lavena - Shumen
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Lavena - Shumen
| When was Lavena - Shumen founded? | Lavena - Shumen was founded in 1962. |
| Where is Lavena - Shumen headquartered? | Lavena - Shumen is headquartered in Bulgaria. |
| How many employees does Lavena - Shumen have? | As of today, Lavena - Shumen has over 151 employees. |
| Is Lavena - Shumen publicly listed? | Yes, Lavena - Shumen is a public company listed on Bulgarian Stock Exchange. |
| What is the stock symbol of Lavena - Shumen? | Lavena - Shumen trades under LAV ticker. |
| When did Lavena - Shumen go public? | Lavena - Shumen went public in 1997. |
| Who are competitors of Lavena - Shumen? | Lavena - Shumen main competitors are Promisia Healthcare, Big Tree Cloud Holdings, Aroma, La savonnerie de Nyons. |
| What is the current market cap of Lavena - Shumen? | Lavena - Shumen's current market cap is $13M. |
| What is the current revenue of Lavena - Shumen? | Lavena - Shumen's last fiscal year revenue is $15M. |
| What is the current EV/Revenue multiple of Lavena - Shumen? | Current revenue multiple of Lavena - Shumen is 0.8x. |
| Is Lavena - Shumen profitable? | No, Lavena - Shumen is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.